Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-05-28 @ 10:39 AM
Study NCT ID:
NCT00000733
Status:
COMPLETED
Last Update Posted:
2021-11-03
First Post:
1999-11-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |